Nicolle Lindsay
Department of Internal Medicine and Medical Microbiology Health Sciences Centre, University of Manitoba, GG443-820 Sherbrook Street, Winnipeg, MB R3A 1R9, Manitoba, Canada.
Expert Opin Pharmacother. 2003 May;4(5):693-704. doi: 10.1517/14656566.4.5.693.
Urinary tract infection is the most frequent bacterial infection. Acute uncomplicated urinary infection and acute non-obstructive pyelonephritis occur in young women with normal genitourinary tracts. Empirical short-course therapy is preferred for the management of acute cystitis, but evolving resistance requires continuing reassessment of optimal antimicrobial selection. Empirical trimethoprim or trimethoprim/sulfamethoxazole has been recommended, but increasing resistance to these agents suggests that pivmecillinam, nitrofurantoin and perhaps fosfomycin trometamol should be considered. Although flouroquinolones are effective as short-course therapy, widespread empirical use of these agents should be discouraged because of potential promotion of resistance. For acute non-obstructive pyelonephritis, flouroquinolones are the empirical oral treatment of choice, although urine culture results should direct continuing therapy. Complicated urinary tract infection occurs in men or women of all ages with underlying abnormalities of the genitourinary tract. Treatment of complicated urinary infection is individualised, taking into consideration the underlying abnormality and susceptibilities of the infecting organism. Asymptomatic bacteriuria should not be treated except in pregnant women, in patients prior to undergoing an invasive surgical procedure, or renal transplant recipients in the early postrenal transplant period.
尿路感染是最常见的细菌感染。急性单纯性尿路感染和急性非梗阻性肾盂肾炎发生于泌尿生殖道正常的年轻女性。经验性短程治疗是急性膀胱炎治疗的首选,但耐药性的不断演变需要持续重新评估最佳抗菌药物的选择。曾推荐经验性使用甲氧苄啶或甲氧苄啶/磺胺甲恶唑,但对这些药物耐药性的增加表明应考虑使用匹美西林、呋喃妥因,或许还有磷霉素氨丁三醇。虽然氟喹诺酮类药物作为短程治疗有效,但由于可能促进耐药性,不应广泛经验性使用这些药物。对于急性非梗阻性肾盂肾炎,氟喹诺酮类药物是经验性口服治疗的选择,不过尿液培养结果应指导后续治疗。复杂性尿路感染发生于所有年龄段有泌尿生殖道潜在异常的男性或女性。复杂性尿路感染的治疗需个体化,要考虑潜在异常情况以及感染病原体的敏感性。无症状菌尿通常无需治疗,除非是孕妇、接受侵入性手术前的患者,或肾移植术后早期的肾移植受者。